AGP Executive Report
Last update: 3 hours agoSpace Biotech & Manufacturing: Outpost Technologies says Exobiosphere will be its first commercial customer on “Space Factories,” flying a microgravity drug-discovery system and returning samples to Earth. Industrial AI in Materials: XtalPi and Fangda Carbon report a predictive AI model has passed acceptance testing and is now running in graphite-electrode production to cut cost and improve material efficiency. Biotech That Delivers for Months: Rice University researchers, via the Rice Biotech Launch Pad, unveiled a “living pharmacy” implant that continuously produces monoclonal antibodies for up to a year in preclinical models. Pharma Manufacturing Investment: Bayer will invest $2.2B in a new Ohio manufacturing site, targeting 600 jobs plus major construction work. Regulatory & Clinical Process: The FDA is recruiting consumer representatives for advisory committees, with deadlines in November. AI Governance in Pharma: PharmTech’s “AI Pulse Check” spotlights data governance, API-gated literature, and limits of AI-content detection. Astronomy: FAST detects the lightest known double neutron star system, PSR J1856–0039, offering a new testbed for extreme physics. Higher Ed Accountability: JMU launches “two-sided” guarantees pairing employment promises for graduates with commitments from hiring employers.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.